Evidence map›Paper›PMID 33431741›Full record

ArticleJournal of clinical and experimental hematopathology : JCEH2021

Transient atelectasis due to hilar lymph node swelling affected by lenalidomide-induced tumor flare reaction.

Takahiro Suyama, Terue Yui, Atsuo Horiuchi, Rie Irie, Yoshiyuki Osamura, Naoki Miyao

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical and experimental hematopathology : JCEH, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Takahiro SuyamaDepartments of Internal Medicine,Nippon Koukan Hospital, Kawasaki, Kanagawa, Japan.
Terue YuiDepartments of Internal Medicine,Nippon Koukan Hospital, Kawasaki, Kanagawa, Japan.
Atsuo HoriuchiDepartments of Internal Medicine,Nippon Koukan Hospital, Kawasaki, Kanagawa, Japan.
Rie IriePathology, Nippon Koukan Hospital, Kawasaki, Kanagawa, Japan.
Yoshiyuki OsamuraPathology, Nippon Koukan Hospital, Kawasaki, Kanagawa, Japan.
Naoki MiyaoDepartments of Internal Medicine,Nippon Koukan Hospital, Kawasaki, Kanagawa, Japan.
Nippon Koei (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor flare reaction (TFR) is a unique immune-mediated tumor recognition phenomenon presenting as rapid enlargement of the tumor, which mimics disease progression, developing in the early stage of treatment using immunomodulatory drugs or immune checkpoint inhibitors. A 59-year-old man with follicular lymphoma had residual tumor burden in the left hilar lymph nodes after R-CHOP therapy, and received lenalidomide and rituximab (R

Indexed as

Antineoplastic Combined Chemotherapy ProtocolsBiopsyCyclophosphamideDoxorubicinHumansImmunologic FactorsLenalidomideLymph NodesLymphoma, FollicularMaleMiddle AgedNeoplasmsPositron Emission Tomography Computed TomographyPrednisonePulmonary AtelectasisRadiography, ThoracicCyclophosphamideDoxorubicinImmunologic FactorsLenalidomidePrednisoneR-CHOP protocolRituximabVincristineImmunomodulatory drugPseudoprogressionTumor flare reaction

Identifiers

PMID33431741
PMCPMC8053573
OpenAlexW3120363999

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.